Searching for a 7-OH Alternative? Compare Product Identity First
People searching for a 7-OH alternative are often arriving at a category full of overlapping names: kratom leaf, mitragynine, MIT tablets, extract powder, 7-hydroxymitragynine, and several newer related substances. The safest way to begin that comparison is not to assume that one product reproduces another. Begin with product identity, documentation, and current rules.
Kratom Paradise does not present MIT products as equivalent to 7-OH, as a treatment for stopping another product, or as a way to reproduce a particular effect. Compare the label terms, physical formats, laboratory records, and current rules without using a conversion chart. No serving recommendation, taper, withdrawal protocol, or medical advice is provided.
First separate the names
| Term | How it is used here | Do not assume |
|---|---|---|
| Mitragynine / MIT | An alkaloid term and a label-organizing term used on current MIT products | That it is another name for 7-OH |
| 7-OH | Shorthand for 7-hydroxymitragynine | That every product using kratom language has the same 7-OH profile |
| MIT tablet | A chewable tablet listing organized by labeled MIT option, flavor, and count | A finished-tablet assay or equivalency from the selector alone |
| MIT extract powder | A concentrate-format listing organized by source line, option, and net weight | That a source report covers every finished package or future lot |
| Botanical kratom | Leaf material commonly sold as powder or leaf-filled capsules | A federal approval or a universal legal status |
Why product format matters
A label can place very different facts beside one another. A tablet may show a milligram selector and a tablet count. An extract pouch may show a percentage product-line name and a net weight. A laboratory report may show percent, milligrams per gram, LOD, LOQ, and a sample ID. Those numbers do not become interchangeable because they appear in the same product family.
For a clean format comparison, use the MIT Products Guide. It separates standard tablets, bulk tablets, standard extract powder, and bulk extract powder without assigning effects or converting one label system into another.
Compare the evidence chain
- Read the complete product title and selected variant.
- Identify the physical format: leaf powder, capsule, chewable tablet, extract powder, or another form.
- Find the sample or lot identity on any document being referenced.
- Check whether the document tested a source concentrate or the finished product.
- Read 7-OH results with their units and reporting limits.
- Keep source-material statements separate from finished-product statements.
- Check the current regulatory status and destination-specific rules before ordering.
The source-material relationship for current Kratom Paradise tablets
Kratom Paradise has confirmed that its current MIT chewable tablets are manufactured using the 90% MIT-CH source concentrate associated with internal sample reference 141690. The available report analyzes that concentrate before tablet manufacturing. It is useful source-material documentation, but it is not a finished-tablet COA.
The source report states 86.87% mitragynine for the submitted concentrate and reports 7-OH as ND with a 0.025 ppm LOQ. Those are results for the identified concentrate sample. They do not establish a finished tablet's complete composition, an exact per-tablet analytical result, every flavor, every package, every production lot, or any legal conclusion.
The current relationship and its limits are recorded in the MIT Product Documents & COA Center. Finished-product testing would provide a different and stronger type of evidence because it would analyze the manufactured tablet rather than its concentrate input.
Questions to answer before ordering
- What is the exact product format?
- What does each selector control?
- What material did the referenced report test?
- What sample, batch, or internal reference appears on the record?
- What were the reported units, LOD, and LOQ?
- Does the statement apply to the source material or the finished product?
- When was the information last reviewed?
Fields to confirm before comparing products
Confirm the physical format, selected option, package quantity, ingredient identity, and document scope together. A source-material record should be identified as source material; a finished-product report should identify the finished item or lot tested. Dated federal status belongs beside the official document and status-check date.
These fields establish what the item is, which evidence applies, and what remains unverified. Recheck them when a source lot, finished-product report, product option, or federal status changes.
Statements that should raise caution
Treat broad phrases such as DEA compliant, federally approved, schedule-proof, guaranteed zero, same effect, safer replacement, or equivalent strength cautiously. Those phrases can imply legal, safety, composition, or performance conclusions that a product name and source-material report do not establish.
A responsible comparison can be useful without promising an outcome. It can explain labels, show where documents fit, disclose what has and has not been tested, and point to current official sources. That is enough to make a shopping decision more informed without turning education into an unsupported product claim.
Related product and document guides
- DEA 7-OH Scheduling Tracker
- 7-OH vs Kratom vs MIT
- MIT Products Guide
- MIT chewable tablets
- MIT extract powder
Official sources and further reading
- DEA July 1, 2026 announcement
- Federal Register notice for 7-OH above specified thresholds
- Federal Register notice for mitragynine pseudoindoxyl, MGM-15, and MGM-16
- FDA consumer information about enhanced 7-OH products
- FDA and Kratom
This material explains product identity, document scope, and regulatory sources. It does not provide medical, serving, withdrawal, equivalency, or legal advice.